Gaucher disease: A diagnostic challenge for internists

European Journal of Internal Medicine

Volumn 25, Issue 2, 2014, Pages 117-124

  Cassinerio, Elena ^a   Graziadei, Giovanna ^a   Poggiali, Erika ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Chitotriosidase; Gaucher disease; Glucocerebroside; Lysosomial disorders; Rare diseases

Indexed keywords

CHITOTRIOSIDASE; GAUCHER DISEASE; GLUCOCEREBROSIDE; LYSOSOMIAL DISORDERS; RARE DISEASES;

EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; GAUCHER DISEASE; HUMANS; INTERNAL MEDICINE;

EID: 84894101153     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.09.006     Document Type: Review

References (107)

1. P. Gaucher De l'epithelioma primitive de la rate, hypertrophie idiopathique de la rate sans leucemie [Doctoral thesis] 1882
2. N.F. Brill, M. Mandelbaum, and E. Libman Primary splenomegaly-Gaucher type. Report on one of four cases occurring in a single generation in one family Am J Med Sci 129 1905 491 504
3. E.F. Neufeld Lysosomal storage disease Ann Rev Biochem 60 1991 257 280
4. K. Suzuki Glucosylceramide and related compounds in normal tissue and in Gaucher disease Prog Clin Biol Res 95 1982 219 230
5. P.K. Mistry, and T.M. Cox The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme J Med Genet 30 1993 889 894
6. M. Filocamo, R. Mazzotti, M. Stroppiano, M. Seri, F. Giona, and G. Parenti et al. Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian Gaucher patients Hum Mutat 20 2002 234 235
7. J. Barranger, and E.I. Ginns Glucosylceramide lipidoses: Gaucher disease The metabolic basis of inherited disease 1989 McGraw-Hill New York
8. A. Vellodi, A. Tylki-Szymanska, E.H. Davies, E. Kolodny, B. Bembi, and T. Collin-Histed et al. Management of neuronopathic Gaucher disease: revised recommendations J Inherit Metab Dis 32 2009 660 664
9. M.E. Grace, K.M. Newman, V. Scheinker, A. Berg-Fussman, and G.A. Grabowsky Analysis of human acid β-glucosidase by site-directed mutagenesis and heterogeneous expression J Biol Chem 269 1994 2283 2291
10. S. Trajkovic-Bodennec, J. Bodonnec, and A.H. Futerman Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes Blood Cells Mol Dis 33 2004 77 82
11. M. Jmudiak, and A. Futerman Gaucher disease: pathological mechanisms and modern management Br J Haematol 129 2005 178 188
12. A. Bitton, J. Etzell, J.P. Grenert, and E. Wang Erythrophagocytosis in Gaucher cells Arch Pathol Lab Med 128 2004 1191 1192
13. L.A. Boven, M. van Meurs, R.G. Boot, A. Mehta, L. Boon, and J.M. Aerts et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages Am J Clin Pathol 122 2004 359 369
14. H. Michelakakis, C. Spanou, A. Kondyli, E. Dimitrou, S. Van Weely, and C.E. Hollak et al. Plasma tumour necrosis factor-a (TNF-a) level in Gaucher disease Biochim Biophys Acta 1317 1996 219 222
15. M.J. Allen, B.J. Myer, A.M. Khokher, N. Rushton, and T.M. Cox Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin 6 and interleukin 10 QJM 90 1997 19 25
16. V. Barak, M. Acker, B. Nisman, I. Kalickman, A. Abrahamov, and A. Zimran et al. Cytokines in Gaucher's disease Eur Cytokine Netw 10 1999 205 210
17. C.E. Hollak, S. van Weely, M.H. van Oers, and J.M. Aerts Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease J Clin Invest 93 1994 1288 1292
18. G.H. Renkema, R.G. Boot, A. Strijland, W.E. Donker-Koopman, M. van den Berg, and A.O. Muijsers et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase Eur J Biochem 244 1997 279 285
19. A. Mekinian, J. Stirnemann, N. Belmatoug, D. Heraoui, B. Fantin, and O. Fain et al. Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment Blood Cells Mol Dis 49 2012 53 57
20. Z. ArIkan-AyyIldIz, A. Yuce, N. Uslu-KIzIlkan, H. Demir, and F. Gurakan Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease Pediatr Blood Cancer 56 2011 664 666
21. B.E. Rosenbloom, N.J. Weinreb, A. Zimran, K.A. Kacena, J. Charrow, and E. Ward Gaucher disease and Cancer Incidence: a study from the Gaucher Registry Blood 105 2005 4569 4572
22. R. Castelli, E. Cassinerio, A. Iurlo, A. Zanella, U. Gianelli, and M.D. Cappellini Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I Am J Hematol 81 2006 383 384
23. A. Zimran, and D. Elstein Lipid storage diseases M.A. Lichtman, T. Kipps, U. Seligsohn, K. Kaushansky, J.T. Prchal, Williams hematology 8th ed. 2010 McGraw-Hill New York, NY 1065 1071
24. E. Beutler, N.J. Nguyen, M.W. Henneberger, J.M. Smolec, R.A. McPherson, and C. West et al. Gaucher disease: gene frequencies in the Ashkenazi Jewish population Am J Hum Genet 52 1993 85 88
25. A. Zimran, A. Kay, T. Gelbart, P. Garver, D. Thurston, and A. Saven et al. Gaucher disease. Clinical, laboratory, radiologic and genetic features of 53 patients Med (Baltimore) 71 1992 337 353
26. S.C. Hill, J.W. Reining, J. Barranger, J. Fink, and T.H. Shawker Gaucher disease: sonographic appearance of the spleen Radiology 160 1984 631 634
27. O. Neudorfer, I. Hadas-Halpem, D. Elstein, A. Abrahamov, and A. Zimran Abdominal ultrasound findings mimicking haematological malignancies in a study of 218 Gaucher patients Am J Hematol 55 1997 28 34
28. C. Niederau, S. vom Dahl, M. Wenning, and D. Haussinger The liver in Gaucher disease Gaucher Clin Perspect 7 1999 9 16
29. C. Niederau, and D. Haussinger Gaucher's disease: a review for the internist and hepatologist Hepatogastroenterology 47 2000 984 997
30. H.S. Chirathivat Quantitative imagining of the liver and spleen in patients Gaucher Clin Perspect 3 1995 1 7
31. H. Rosenbaum, and E. Sindransky Cholelithiasis in patients with Gaucher disease Blood Cells Mol Dis 28 2002 21
32. T.H. Taddei, J. Dziura, S. Chen, R. Yang, H. Hyogo, and C. Sullards et al. High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease J Inherit Metab Dis 33 2010 291 300
33. T. Cox, and J. Schofield Gaucher's disease clinical factures and natural history A. Zimran, Gaucher's disease 10 1997 W. B. Saunders London 657 690
34. A. Shiran, B. Brenner, A. Laor, and I. Tatarsky Increased risk of cancer in patients with Gaucher disease Cancer 72 1993 219 224
35. R. Xu, P. Mistry, G. Mckenna, S. Emre, T. Schiano, and M. Bu-Ghanim et al. Gaucher disease: a case report with review of the literature Semin Liver Dis 25 2005 226 229
36. M. de Fost, S. Vom Dahl, G.J. Weverling, N. Brill, D. Haussinger, and C.E. Hollak Increased incidence of cancer in adult Gaucher disease in Western Europe Blood Cells Mol Dis 36 2006 53 58
37. D. Hughes, M. Cappellini, M. Berger, J. Van Droogenbroeck, M. de Fost, and D. Janic et al. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease Br J Haematol 138 2007 676 686
38. C.E. Hollak, M. Levi, F. Berends, J.M. Aerts, and M.H. van Oers Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy Br J Haematol 96 1997 470 476
39. A. Deghady, I. Marzouk, A. El-Shayeb, and Y. Wali Coagulation abnormalities in type 1 Gaucher disease in children Pediatr Hematol Oncol 23 1996 411 417
40. S. Gillis, E. Hyam, A. Abrahamov, D. Elstein, and A. Zimran Platelet function abnormalities in Gaucher disease patients Am J Hematol 61 1999 103 106
41. C.E. Hollak, M. Mass, and J.M. Aerts Clinically relevant therapeutic endpoints in type 1 Gaucher disease J Inherit Metab Dis 24 2001 97 105 [Suppl.]
42. D.W. Stowens, S.L. Teitelbaum, A.J. Kahn, and A.J. Barranger Skeletal complication of Gaucher disease Medicine 64 1985 310 322
43. R.J. Wenstrup, M. Roca-Espiau, N.J. Weinreb, and B. Bembi Skeletal aspects of Gaucher disease: a review Br J Radiol 75 2002 A2 A12
44. J. Charrow, H.C. Andersson, P. Kaplan, E.H. Kolodny, P. Mistry, and G. Pastores et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease Arch Intern Med 160 2000 2835 2843
45. E. Kerem, D. Elstein, A. Abrahamov, Y. Bar Ziv, I. Hadas-Halpem, and E. Malzer et al. Pulmonary function abnormalities in type I Gaucher disease Eur Respir J 9 1996 340 345
46. A. Miller, L.K. Brown, G.M. Pastores, and R.J. Desnick Pulmonary involvement in type I Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease Clin Genet 63 2003 368
47. G. Armir, and N. Ron Pulmonary pathology in Gaucher's disease Hum Pathol 30 1999 666 670
48. A. Dawson, D.J. Elias, D. Rubenson, S.H. Bartz, P.R. Garver, and A.C. Kay et al. Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by hepatopulmonary syndrome Ann Intern Med 125 1996 901 904
49. M.M. Hoeper, J. Niedermeyer, F. Hoffmeyer, P. Flemming, and H. Fabel Pulmonary hypertension after splenectomy? Ann Intern Med 130 1999 506 509
50. P.K. Mistry, S. Sirrs, A. Chan, M.R. Pritzker, T.P. Duffy, and M.E. Grace et al. Pulmonary hypertension in type I Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy Mol Genet Metab 77 2002 91 98
51. A. Siegal, A. Gutman, M.S. Shapiro, and B. Griffel Renal involvement in Gaucher's disease Postgrad Med J 57 1981 398 401
52. P. Giraldo, J.I. Solano, M.G. Perez-Calvo, and D. Rubion-Felix Quality of life related to type I Gaucher disease: Spanish experience Qual Life Res 14 2005 453 462
53. E.B. Chetrit, R.N. Alcalay, B. Steiner-Birmanns, G. Altarescu, M. Phillips, and D. Elstein et al. Phenotype in patients with Gaucher disease and Parkinson disease Blood Cells Mol Dis 50 2013 218 221
54. G. Bultron, K. Kacena, D. Pearson, M. Boxer, R. Yang, and S. Sathe et al. The risk of Parkinson's disease in type 1 Gaucher disease J Inherit Metab Dis 33 2010 167 173
55. T. Cox Gaucher disease: clinical profile and therapeutic developments Biologics 4 2010 299 313
56. R. George, J. McMahon, B. Lytle, B. Clark, and A. Lichtin Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation Clin Genet 59 2001 360 363
57. G.E. Marti, E.T. Ryan, N.M. Papadopoulos, M. Filling-Katz, N. Barton, and T.A. Fleischer et al. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease Am J Hematol 29 1994 189 194
58. M. de Fost, T.A. Out, F.A. de Wilde, E.P. Tjin, S.T. Pals, and M.H. van Oers et al. Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature Ann Hematol 87 2008 439 449
59. A. Zimran, I. Liphshitz, M. Barchana, A. Abrahamov, and D. Elstein Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic Blood Cells Mol Dis 34 2005 197 200
60. D.L. Stone, W.F. Carey, J. Christodoulou, D. Sillence, P. Nelson, and M. Callahan et al. Type 2 Gaucher disease: the collodion baby phenotype revisited Arch Dis Child Fetal Neonatal Ed 82 2000 163 166
61. International Collaborative Gaucher Group (ICGG) Gaucher registry annual report 2010 www.gaucherregistry.com
62. E. Beutler Gaucher disease N Eng J Med 325 1991 1354 1360
63. D.J. Halsall, G. Kriegshauer, A. Moritz, T.S. Elsey, and C. Oberkanins Rapid genetic testing for Gaucher disease by reverse hybridization Ann Clin Biochem 40 2003 419 421
64. G.A. Grabowski Gaucher disease: gene frequencies and genotype/phenotype correlations Genet Test 1 1997 5 12
65. N.A. Chamoles, M. Blanco, D. Gaggioli, and C. Casentini Gaucher and Niemann-Pick diseases. Enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnosis in newborn-screening cards Clin Chim Acta 317 2002 191 197
66. P. Olivova, E. Cullen, M. Titlow, H. Kallwass, J. Barranger, and K. Zhang An improved high-throughput dried blood spot screening method for Gaucher disease Clin Chim Acta 398 2008 163 164
67. J.M. Aerts, M.J. van Breeemen, A.P. Bussinik, K. Ghauarali, R. Sprenger, and R.G. Boot Biomarkers for lysosomial storage disorders: identification and application as exemplified by chitotriosidase in Gaucher disease Acta Paediatr Suppl 97 2008 7 14
68. P.B. Deegan, and T.M. Cox Clinical evaluation of biomarkers in Gaucher disease Acta Paediatr Suppl 94 2005 47 50
69. A. Vellodi, Y. Foo, and T.J. Cole Evaluation of three markers in the monitoring of Gaucher disease J Inherit Metab Dis 28 2005 585 592
70. K.P. Mistry, M.D. Cappellini, E. Lukina, H. Ozsan, S.M. Pasqual, and H. Rosenbaum et al. A reappraisal of Gaucher disease. Diagnosis and disease management algorithms Am J Hematol 86 2011 110 115
71. L.W. Poll, J.A. Koch, S. vom Dahl, R. Willers, A. Scherer, and D. Boerner et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results Skeletal Radiol 9 2001 496 503
72. M.R. Terk, S. Dardashti, and H.A. Liebman Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume Skeletal Radiol 29 2000 563 571
73. N.J. Weinreb, M.C. Aggio, H.C. Andersson, G. Andria, J. Charrow, and J.T.R. Clarke et al. Gaucher disease type I: revised recommendations on evaluations and monitoring for adult patients Semin Hematol 41 2004 15 22
74. M.A. Cabrera-Salazar, E. O'Rourke, N. Henderson, H. Wessel, and J.A. Barranger Correlation of surrogate markers of Gaucher disease: implications for long-term follow up of enzyme replacement therapy Clin Chim Acta 344 2004 101 107
75. M. de Fost, C.E. Hollak, J.E. Groener, J.M. Aerts, M. Maas, and L.W. Poll Superior effect of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis Blood 108 2006 830 835
76. T.M. Cox, J.M. Aerts, N. Belmatoug, M.D. Cappellini, S. vom Dahl, and J. Goldblatt et al. Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosponate therapy, use of biomarkers and bone disease monitoring J Inherit Metab Dis 31 2008 319 336
77. M. Di Rocco, F. Giona, F. Carubbi, S. Linari, F. Minichilli, and R.O. Brady et al. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease Haematologica 93 2008 1211 1218
78. A. Zimran, D. Elstein, E. Lewy-Lahad, S. Zevin, I. Hadas-Halpern, and Y. Bar-Ziv et al. Replacement therapy with imiglucerase for type 1 Gaucher's disease Lancet 345 1995 1479 1480
79. G.A. Grabowski, N.W. Barton, G. Pastores, J.M. Dambrosia, T.K. Benerjee, and M.A. McKee Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources Ann Intern Med 122 1995 33 39
80. G.A. Grabowski, K. Kacena, J.A. Cole, C.E. Hollak, L. Zhang, and J. Yee Dose response relationship for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1 Genet Med 11 2009 92 100
81. G.M. Pastores, N.J. Weinreb, H. Aerts, G. Andria, T.M. Cox, and M. Giralt et al. Therapeutic goals in the treatment of Gaucher disease Semin Hematol 41 2004 4 14
82. M.D. Cappellini, R. Castelli, and E. Cassinerio Gaucher disease-pathophysiology and management of adult patients Business briefing: European pharmacotherapy 2006
83. F.L. Oliveira, T. Alegra, A. Dornelles, B.C. Krug, C.B. Netto, and N.S. da Rocha et al. Quality of life of Brazilian patients with Gaucher disease and Fabry disease JIMD Rep 7 2013 31 37
84. N.W. Barton, R.O. Brady, J.M. Dambrosia, A.M. Di Bisceglie, S.H. Doppelt, and S.C. Hill et al. Replacement therapy for inherited enzyme deficiency: macrophage-targeted glucocerebrosidase for Gaucher disease N Engl J Med 324 1991 1464 1470
85. H.C. Andersson, J. Charrow, P. Kaplan, P. Mistry, G.M. Pastores, and A. Prakesh-Cheng et al. Individualization of long-time enzyme replacement therapy for Gaucher disease Genet Med 7 2005 105 110
86. P.K. Mistry, N.J. Weinrreb, P. Kaplan, J.A. Cole, A.R. Gwosdow, and T. Hangartner Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults Blood Cells Mol Dis 46 2011 66 72
87. A. Zimran How I, treat Gaucher disease Blood 118 2011 1463 1471
88. G. Altarescu, S. Hill, E. Wiggs, N. Jeffries, C. Kreps, and C.C. Parker et al. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease J Pediatr 138 2001 439 447
89. A. Zimran, and D. Elstein No justification for very high-dose enzyme therapy for patients with type III Gaucher disease J Inherit Metab Dis 30 2007 843 844
90. K.E. Bove, C. Daugherty, and G.A. Grabowski Pathological findings in Gaucher disease type 2 patients following enzyme therapy Hum Pathol 26 1995 1040 1045
91. A. Zimran, K. Loveday, C. Fratazzi, and D. Elstein A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease Blood Cells Mol Dis 39 2007 115 118
92. A. Zimran, G. Altarescu, M. Philips, D. Attias, M. Jmoudiak, and M. Deeb et al. Phase 1-2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-months experience Blood 115 2010 4651 4656
93. D. Elstein, G.M. Cohn, N. Wang, M. Djordjevic, C. Brutaru, and A. Zimran Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease Blood Cells Mol Dis 46 2011 119 123
94. Y. Shaaltiel, D. Bartfeld, S. Hasmueli, G. Baum, E. Brill-Almon, and G. Galili Production of glucocerebosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system Plant Biotechnol J 5 2007 579 590
95. D. Aviezer, E. Brill-Almon, Y. Shaaltiel, S. Hasmueli, D. Bartfeld, and S. Mizrachi A plant-derived recombinant human glucocerebrosidase enzyme- a preclinical and phase I investigation PLoS One 4 2009 e4792
96. T.M. Cox, R. Lachmann, C. Hollak, J. Aerts, S. van Weely, and M. Hrebicek et al. Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis Lancet 355 2000 1481 1485
97. R. Schiffmann, E.J. Fitzgibbon, C. Harris, C. DeVile, E.H. Davies, and L. Abel et al. Randomized controlled trial of miglustat in Gaucher's disease type 3 Ann Neurol 64 2008 514 522
98. D. Elstein, C. Hollak, J.M. Aerts, S. van Weely, S. Maas, and T.M. Cox et al. Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease J Inherit Metab Dis 27 2004 757 766
99. E. Lukina, N. Watman, E.A. Arreguin, M. Dragosky, M. Iastrebner, and H. Rosenbaum et al. Improvement in haematological, visceral and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study Blood 116 2010 4095 4098
100. G.J. Kornhaber, M.B. Tropak, G.H. Maegawa, S.J. Tuske, S.J. Coales, and D.J. Mahuran et al. Isofagomine induced stabilization of glucocerebrosidase Chembiochem 9 2008 2643 2649
101. C. Niederau Gaucher disease. Unimed Science 2nd ed. 2009
102. S. Fabrega, and P. Lehn Gene therapy of Gaucher's and Fabry's diseases: current status and prospects J Soc Biol 196 2002 175 181
103. S.J. Ostlere, and R.H. Gold Osteoporosis and bone density measurements methods Clin Orthop Relat Res 271 1991 149 163
104. R.J. Wenstrup, L. Bailey, G.A. Grabowsky, J. Moskovitz, A.E. Oestreich, and W. Wu et al. Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy Blood 104 2004 1253 1257
105. B. Bembi, M. Zanatta, M. Carrozzi, F. Baralle, R. Gornati, and B. Berra et al. Enzyme replacement treatment in type 1 and type 3 Gaucher's disease Lancet 344 1994 1679 1682
106. E. Lebel, M. Itzchaki, I. Hadas-Halpern, A. Zimran, and D. Elstein Outcome of total hip arthroplasty in patients with Gaucher disease J Arthroplasty 16 2001 7 12
107. S. Granovsky-Grisaru, N. Belmatoug, S. vom Dahl, E. Mengel, E. Morris, and A. Zimran The management of pregnancy in Gaucher disease Eur J Obstet Gynecol Reprod Biol 156 2011 3 8